Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation. [electronic resource]
Producer: 20190506Description: 2056-2064 p. digitalISSN:- 1534-6080
- Carcinoma, Hepatocellular -- mortality
- Case-Control Studies
- Drug Administration Schedule
- Everolimus -- administration & dosage
- Female
- Humans
- Immunosuppressive Agents -- administration & dosage
- Liver Neoplasms -- mortality
- Liver Transplantation -- adverse effects
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Progression-Free Survival
- Prospective Studies
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.